BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17543560)

  • 1. The correction of BMD measurements for bone strontium content.
    Blake GM; Fogelman I
    J Clin Densitom; 2007; 10(3):259-65. PubMed ID: 17543560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bone strontium on BMD measurements.
    Blake GM; Fogelman I
    J Clin Densitom; 2007; 10(1):34-8. PubMed ID: 17289524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term treatment with strontium ranelate on bone strontium content.
    Bärenholdt O; Kolthoff N; Nielsen SP
    Bone; 2009 Aug; 45(2):200-6. PubMed ID: 19376283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of bone strontium on BMD is different for different manufacturers' DXA Systems.
    Liao J; Blake GM; McGregor AH; Patel R
    Bone; 2010 Nov; 47(5):882-7. PubMed ID: 20699129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.
    Anastasilakis AD; Polyzos SA; Avramidis A; Papatheodorou A; Terpos E
    Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical model for the interpretation of BMD scans in patients stopping strontium ranelate treatment.
    Blake GM; Fogelman I
    J Bone Miner Res; 2006 Sep; 21(9):1417-24. PubMed ID: 16939400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.
    Farlay D; Boivin G; Panczer G; Lalande A; Meunier PJ
    J Bone Miner Res; 2005 Sep; 20(9):1569-78. PubMed ID: 16059629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of dual energy X-ray and laser absorptiometry of the calcaneus versus dual energy X-ray absorptiometry of hip and spine in diagnosing manifest osteoporosis.
    de Klerk G; van der Velde D; van der Palen J; van Bergeijk L; Hegeman JH
    Arch Orthop Trauma Surg; 2009 Feb; 129(2):251-7. PubMed ID: 18825395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
    Boivin G; Meunier PJ
    Osteoporos Int; 2003; 14 Suppl 3():S19-24. PubMed ID: 12730799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a Swedish T-score reference population for women causes a two-fold increase in the amount of postmenopausal Swedish patients that fulfill the WHO criteria for osteoporosis.
    Ribom EL; Ljunggren O; Mallmin H
    J Clin Densitom; 2008; 11(3):404-11. PubMed ID: 18280191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium is incorporated in different levels into bones and teeth of rats treated with strontium ranelate.
    Oliveira JP; Querido W; Caldas RJ; Campos AP; Abraçado LG; Farina M
    Calcif Tissue Int; 2012 Sep; 91(3):186-95. PubMed ID: 22806682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration.
    Boivin G; Deloffre P; Perrat B; Panczer G; Boudeulle M; Mauras Y; Allain P; Tsouderos Y; Meunier PJ
    J Bone Miner Res; 1996 Sep; 11(9):1302-11. PubMed ID: 8864905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of strontium ranelate treatment on BMD.
    Blake GM; Fogelman I
    J Bone Miner Res; 2005 Nov; 20(11):1901-4. PubMed ID: 16234961
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of increasing vertebral marrow fat content on BMD measurement, T-Score status and fracture risk prediction by DXA.
    Blake GM; Griffith JF; Yeung DK; Leung PC; Fogelman I
    Bone; 2009 Mar; 44(3):495-501. PubMed ID: 19059505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructure.
    Busse B; Jobke B; Hahn M; Priemel M; Niecke M; Seitz S; Zustin J; Semler J; Amling M
    Acta Biomater; 2010 Dec; 6(12):4513-21. PubMed ID: 20654744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related bone mineral density, bone loss rate, prevalence of osteoporosis, and reference database of women at multiple centers in China.
    Cheng XG; Yang DZ; Zhou Q; Zhuo TJ; Zhang HC; Xiang J; Wang HF; Ou PZ; Liu JL; Xu L; Huang GY; Huang QR; Barden HS; Weynand LS; Faulkner KG; Meng XW
    J Clin Densitom; 2007; 10(3):276-84. PubMed ID: 17604665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
    Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
    Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density of the spine and femur in a group of healthy Moroccan men.
    El Maghraoui A; Ghazi M; Gassim S; Mounach A; Ghozlani I; Nouijai A; Achemlal L; Bezza A; Dehhaoui M
    Bone; 2009 May; 44(5):965-9. PubMed ID: 19168162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ascites on bone density measurement in cirrhosis.
    Labio ED; Del Rosario DB; Strasser SI; McCaughan GW; Crawford BA
    J Clin Densitom; 2007; 10(4):391-4. PubMed ID: 17703977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dual-energy X-ray absorptiometry in clinical practice and its trouble spots in bone mineral measurement].
    Hagino H
    Clin Calcium; 2004 Dec; 14(12):33-8. PubMed ID: 15577171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.